SLE is characterised by the production of antibodies against RNA-containing protein complexes such as Sm, RNP, Ro, and La, which subsequently promotes the TLF-7 medicated production of IFNα [223]. The gene discussed is CALR; the disease is systemic lupus erythematosus.